Real-World Precision Medicine: Proteogenomics to Accelerate Drug Development and Patient Care (90minutes)
October 18, 2021
08:00 PDT (UTC-7), 11:00 EDT (UTC-4), 15:00 UTC
Ever since the announcement of the Precision Medicine Initiative, there have been increasing efforts to identify and understand the basis of cancer using high-throughput technologies and the development of specialized treatments for specific subtypes of cancer, based on molecular evidence. Clinical proteogenomics is an exciting opportunity to complement the gene testing-centric clinical community for precision medicine. However, translating proteomic measurements to real-world patient care requires synergy of multiple requirements: meaningful and actionable molecular characterization, clinical and analytical validation, defining diagnosis values, and meeting regulatory compliance.
Speakers:
Register for the webinar.
.png)
